PyInvesting

Market research

004720.KO PharmGen Science Inc

KO KRW Healthcare

Latest close

2,965.00 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
67B
P/E ratio
554.99
Analyst target
Not available
Dividend yield
Not available
Beta
0.38

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Wooridul Pharmaceutical Limited is currently in a long term uptrend where the price is trading 14.1% above its 200 day moving average.

From a valuation standpoint, the stock is 83.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.

Wooridul Pharmaceutical Limited's total revenue rose by 9.8% to $26B since the same quarter in the previous year.

Its net income has increased by 967.6% to $6B since the same quarter in the previous year.

Finally, its free cash flow grew by 87.5% to $-282M since the same quarter in the previous year.

Based on the above factors, Wooridul Pharmaceutical Limited gets an overall score of 5/5.